Relationship of Serum Apolipoprotein A-V Levels, Oxidative Stress and Inflammatory Biomarkers with Hypertriglyceridemia in Type 2 Diabetes Mellitus

Authors Information
Article Notes and Dates
To Cite : Sharma D, Garg S, Mehndiratta M, V Madhu S, Puri D. et al. Relationship of Serum Apolipoprotein A-V Levels, Oxidative Stress and Inflammatory Biomarkers with Hypertriglyceridemia in Type 2 Diabetes Mellitus, Int J Endocrinol Metab. 2017 ;15(2):e44805. doi: 10.5812/ijem.44805.
Copyright: Copyright © 2017, International Journal of Endocrinology and Metabolism. .
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. International Diabetes Federation. . IDF Diabetes Atlas. 2016;
  • 2. Festa A, D'Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome : The insulin resistance atherosclerosis study (iras). Circulation. 2000; 102(1): 42-7[DOI]
  • 3. Grunfeld C, Dinarello CA, Feingold KR. Tumor necrosis factor-α, interleukin-1, and interferon alpha stimulate triglyceride synthesis in HepG2 cells. Metabolism. 1991; 40(9): 894-8[DOI]
  • 4. National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106(25): 3143-421[PubMed]
  • 5. Dallinga-Thie GM, van Tol A, Hattori H, van Vark-van der Zee LC, Jansen H, Sijbrands EJ, et al. Plasma apolipoprotein A5 and triglycerides in type 2 diabetes. Diabetologia. 2006; 49(7): 1505-11[DOI][PubMed]
  • 6. Ishihara M, Kujiraoka T, Iwasaki T, Nagano M, Takano M, Ishii J, et al. A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration. J Lipid Res. 2005; 46(9): 2015-22[DOI][PubMed]
  • 7. Pennacchio LA, Olivier M, Hubacek JA, Krauss RM, Rubin EM, Cohen JC. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet. 2002; 11(24): 3031-8[PubMed]
  • 8. American Diabetes A. Standards of medical care in diabetes--2013. Diabetes Care. 2013; 36 Suppl 1-66[DOI][PubMed]
  • 9. Devasagayam TP, Boloor KK, Ramasarma T. Methods for estimating lipid peroxidation: an analysis of merits and demerits. Indian J Biochem Biophys. 2003; 40(5): 300-8[PubMed]
  • 10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7): 412-9[PubMed]
  • 11. Armstrong C, Joint National C. JNC8 guidelines for the management of hypertension in adults. Am Fam Physician. 2014; 90(7): 503-4[PubMed]
  • 12. The IDF consensus worldwide definition of the metabolic syndrome. .
  • 13. International Diabetes Federation. . DF Diabetes Atlas. 2015;
  • 14. Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia. 1998; 41(10): 1241-8[DOI][PubMed]
  • 15. Hodoglugil U, Tanyolac S, Williamson DW, Huang Y, Mahley RW. Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turks. J Lipid Res. 2006; 47(1): 144-53[DOI][PubMed]
  • 16. Calandra S, Priore Oliva C, Tarugi P, Bertolini S. APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency. Curr Opin Lipidol. 2006; 17(2): 122-7[DOI][PubMed]
  • 17. Merkel M, Loeffler B, Kluger M, Fabig N, Geppert G, Pennacchio LA, et al. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J Biol Chem. 2005; 280(22): 21553-60[DOI][PubMed]
  • 18. Weinberg RB, Cook VR, Beckstead JA, Martin DD, Gallagher JW, Shelness GS, et al. Structure and interfacial properties of human apolipoprotein A-V. J Biol Chem. 2003; 278(36): 34438-44[DOI][PubMed]
  • 19. Pruneta-Deloche V, Ponsin G, Groisne L, Fruchart-Najib J, Lagarde M, Moulin P. Postprandial increase of plasma apoAV concentrations in Type 2 diabetic patients. Atherosclerosis. 2005; 181(2): 403-5[DOI][PubMed]
  • 20. Murray RK. Lipid transport and storage. In: Harper's illustrated biochemistry. 2012; : 212-23
  • 21. Shao L, Feng B, Zhang Y, Zhou H, Ji W, Min W. The role of adipose-derived inflammatory cytokines in type 1 diabetes. Adipocyte. 2016; 5(3): 270-4[DOI][PubMed]
  • 22. Al-Aubaidy HA, Jelinek HF. Oxidative stress and triglycerides as predictors of subclinical atherosclerosis in prediabetes. Redox Rep. 2014; 19(2): 87-91[DOI][PubMed]
  • 23. Wright E Jr, Scism-Bacon JL, Glass LC. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int J Clin Pract. 2006; 60(3): 308-14[DOI][PubMed]
  • 24. Katsuki A, Sumida Y, Urakawa H, Gabazza EC, Murashima S, Nakatani K, et al. Increased oxidative stress is associated with serum levels of triglyceride, insulin resistance, and hyperinsulinemia in Japanese metabolically obese, normal-weight men. Diabetes Care. 2004; 27(2): 631-2[PubMed]
  • 25. Gomez-Marcos MA, Blazquez-Medela AM, Gamella-Pozuelo L, Recio-Rodriguez JI, Garcia-Ortiz L, Martinez-Salgado C. Serum Superoxide Dismutase Is Associated with Vascular Structure and Function in Hypertensive and Diabetic Patients. Oxid Med Cell Longev. 2016; 2016: 9124676[DOI][PubMed]
  • 26. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004; 114(12): 1752-61[DOI][PubMed]
  • 27. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med. 2005; 11(2): 191-8[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiaion Alert via Google Reader

Cited By:

International Journal of Endocrinology and Metabolism accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check